Senior Scientists' Experience Can Offer A Valuable Resource To Today's Students

A large and growing group of individuals -- the seniors -- is being chased out of our factories, our offices, our classrooms, our boardrooms, and in fact out of all aspects of active professional life. Although America is aging, and the mean age creeps up inexorably, institution after institution has programs designed to get rid of any gray heads with many years of experience and faithful service and replace them with younger, cheaper, and often part-time employees. AT&T, IBM, and other b

Written byMurray Saffran
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

A large and growing group of individuals -- the seniors -- is being chased out of our factories, our offices, our classrooms, our boardrooms, and in fact out of all aspects of active professional life. Although America is aging, and the mean age creeps up inexorably, institution after institution has programs designed to get rid of any gray heads with many years of experience and faithful service and replace them with younger, cheaper, and often part-time employees.

AT&T, IBM, and other big-business names are downsizing. One of their powerful pruning tools is to coax old-timers into retirement with seemingly attractive retirement packages. Many of these strategies have succeeded, leaving factories and offices devoid of workers over 55 years old.

The urge to de-age the work force has reached the universities. Using the same tactics as industry, academe is offering early-retirement schemes that lure senior faculty into nonproductive lives. As a ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies